eli lilly and company news

Is Eli Lilly and Company (LLY) the Best Blue Chip Stock to Buy for 2025?

We recently published a list of 10 Best Blue Chip Stocks to Buy for 2025. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best blue chip stocks to buy for 2025.

The Motley Fool · 12d

Is Eli Lilly Stock a Buy?

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 (GLP-1) receptor agonist drugs. The stock is up about 36% year to date as of this writing and has gained around 506% over the past five years.

Business Insider · 2d

Truist Financial Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price

24/7 Wall St · 1d

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and currently trading at $773.28. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,

Zacks.com on MSN · 2d

Why the Market Dipped But Eli Lilly (LLY) Gained Today

In the latest trading session, Eli Lilly (LLY) closed at $773.29, marking a +1.07% move from the previous day. The stock outpaced the S&P 500's daily loss of 1.11%. On the other hand, the Dow registered a loss of 0.

19hon MSN

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Eli Lilly and Company to set-up global capability centre in Hyderabad, to recruit over 1,000 skilled workers

The company said that it would be recruiting more than a 1,000 highly-skilled team members to strengthen its digital strategy ...

Yahoo Finance1d

Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with ...

Eli Lilly & Co. stock underperforms Tuesday when compared to competitors despite daily gains

Eli Lilly & Co. closed $199.24 short of its 52-week high ($972.53), which the company achieved on August 22nd.

Nasdaq6d

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Eli Lilly (LLY) has been one of the most searched ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to ...

Eli Lilly setting up GCC in Hyderabad, to hire over 1,000 people

Eli Lilly & Company to establish new global capability centre in Hyderabad, recruiting over 1,000 professionals for advanced ...

Insider Monkey10d

Is Eli Lilly and Company (LLY) the Best Pharma Dividend Stock to Buy In 2024?

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively ...